Physician profile
Michael R Recto
NPI 1013912674
$4,152.08
in general payments reported to CMS, 2019-2025
9 companies · $70.25 in 2025
The $70.25 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,277 · 2021: $28.87 · 2022: $1,756 · 2023: $351 · 2024: $669 · 2025: $70.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732 · Travel and Lodging: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.32 |
| Travel and Lodging | $357.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,739.22 | 2022-2024 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Medtronic Vascular, INC. | $1,277.13 | 2019 | |
| Abbott Laboratories | $341.31 | 2023-2024 | Amplatzer, Amplatzer Piccolo |
| Medtronic, INC. | $287.79 | 2021-2024 | Harmony, Concertotm |
| Terumo Medical Corporation | $161.38 | 2022-2023 | Metacross Otw, Progreat |
| Biosense Webster, INC. | $132.31 | 2022 | |
| Janssen Pharmaceuticals, INC | $121.36 | 2022 | |
| Renata Medical, INC. | $70.25 | 2025 | Minima Stent System - 8mm, Minima Stent System - 6mm |
| Pierre Fabre Pharmaceuticals, INC. | $21.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Recto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.